Zena Burgess
Director/Board Member at MINDBIO THERAPEUTICS CORP.
Profile
Zena Burgess currently works at Australian Psychological Society, as Chief Executive Officer, Australian Patients Association Ltd., as Director, MindBio Therapeutics Pty Ltd., as Non-Executive Director, and Mindbio Therapeutics Corp., as Non-Executive Director from 2023.
Dr. Burgess also formerly worked at Royal Australian College of General Practitioners, as Chief Executive Officer.
Dr. Burgess received her Masters Business Admin degree from Monash University, doctorate degree from Australian Catholic University, and graduate degree from LaTrobe University.
Zena Burgess active positions
Companies | Position | Start |
---|---|---|
MINDBIO THERAPEUTICS CORP. | Director/Board Member | 2023-03-27 |
MindBio Therapeutics Pty Ltd.
MindBio Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology MindBio Therapeutics Pty Ltd. is a multi-award-winning leader in microdosing psychedelic medicines. The company is based in Melbourne, Australia, and has subsidiaries in Australia. MindBio Therapeutics is focused on creating treatments for mental health conditions, and its clinical trials focusing on microdosing psychedelic medicines provide hope for sufferers of mental health conditions. The Australian company has conducted a randomized, double-blind, placebo-controlled trial to study the effects of repeated microdoses of lysergic acid diethylamide (LSD) on creativity and brain activity in healthy adult males. MindBio Therapeutics was founded by Justin Adam Hanka, and the CEO is Colin Keating. | Director/Board Member | - |
Australian Patients Association Ltd.
Australian Patients Association Ltd. Medical/Nursing ServicesHealth Services The Australian Patients Association Ltd. is an independent not-for-profit organization that advocates for positive patient improvement and champions the rights and interests of patients in Australia. The Australian Patients Association is based in Melbourne, Australia, and Stephen Leslie Mason has been the CEO of the company since 2011. The association influences the development of national healthcare policy and reform to improve patient care and health outcomes for all Australians. The Australian company provides patient advocacy, information, and support, and offer special benefits to their members. The association values the input of patients and conducts surveys to understand their concerns and needs. | Director/Board Member | - |
Australian Psychological Society | Chief Executive Officer | - |
Former positions of Zena Burgess
Companies | Position | End |
---|---|---|
Royal Australian College of General Practitioners | Chief Executive Officer | - |
Training of Zena Burgess
Monash University | Masters Business Admin |
Australian Catholic University | Doctorate Degree |
LaTrobe University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
MINDBIO THERAPEUTICS CORP. | Health Technology |
Private companies | 3 |
---|---|
Australian Psychological Society | |
Australian Patients Association Ltd.
Australian Patients Association Ltd. Medical/Nursing ServicesHealth Services The Australian Patients Association Ltd. is an independent not-for-profit organization that advocates for positive patient improvement and champions the rights and interests of patients in Australia. The Australian Patients Association is based in Melbourne, Australia, and Stephen Leslie Mason has been the CEO of the company since 2011. The association influences the development of national healthcare policy and reform to improve patient care and health outcomes for all Australians. The Australian company provides patient advocacy, information, and support, and offer special benefits to their members. The association values the input of patients and conducts surveys to understand their concerns and needs. | Health Services |
MindBio Therapeutics Pty Ltd.
MindBio Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology MindBio Therapeutics Pty Ltd. is a multi-award-winning leader in microdosing psychedelic medicines. The company is based in Melbourne, Australia, and has subsidiaries in Australia. MindBio Therapeutics is focused on creating treatments for mental health conditions, and its clinical trials focusing on microdosing psychedelic medicines provide hope for sufferers of mental health conditions. The Australian company has conducted a randomized, double-blind, placebo-controlled trial to study the effects of repeated microdoses of lysergic acid diethylamide (LSD) on creativity and brain activity in healthy adult males. MindBio Therapeutics was founded by Justin Adam Hanka, and the CEO is Colin Keating. | Health Technology |
- Stock Market
- Insiders
- Zena Burgess